Multiple sclerosis

References

• Cruveilheir J. Anatomic pathologique du corps humain, Paris: JB Baillière, 1835
   Google Scholar
• Carswell R. Pathological anatomy: illustrations on the elementary forms of disease. London: Longman. Orme, Brown. Green & Longman. 1838
   Google Scholar
• Charcot JM. Histologie de la sclérose en plaques. Gaz Hôp (Paris) 1868: 41: 554–66
   Google Scholar
• Adams CW. The general pathology of multiple sclerosis: morphological and chemical aspects of the lesions, In: Hallpike JF. Adams CW. Tourtellotte WW. eds. Multiple sclerosis: pathology, diagnosis and management. London: Chapman & Hall. 1983
   Google Scholar
• Itoyama Y. Sternberger NH, Webster HD, et al. Immunocytochemical observations on the distribution of myelin-associated glycoprotein and myelin basic protein in multiple sclerosis lesions, Ann Neurol 1980: 7(2): 167–77
   Google Scholar
• Prineas JW, Wright RG. Macrophages, lymphocytes. and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab Invest 1978: 38(4): 409–21
   PubMed Web of Science ®Google Scholar
• Tourtellotte WW. Murphy K, Brandes D. Schemes to eradicate the multiple sclerosis CNS immune reaction. Neurology 1976: 26(6 Pt 2): 59–61
   PubMed Web of Science ®Google Scholar
• Link H. Oligoclonal immunoglobulin G in multiple sclerosis brains. J Neurosci 1972: 16(1): 103–14
   Google Scholar
• Antel JP, Arnason BG. Medoff ME. Suppressor cell function in multiple sclerosis: correlation with clinical disease activity. Ann Neurol 1979: 5(4): 338–42
   PubMed Web of Science ®Google Scholar
• Meade CJ, Mertin J. Fatty acids and immunity. Adv Lipid Res 1978: 16: 127–65
   PubMedGoogle Scholar
• Haase AT, Ventea P, Gibbs CJ Jr, et al. Measles virus nucleotide sequences: detection by hybridization in situ. Science 1981: 212(4495): 672–5
   PubMed Web of Science ®Google Scholar
• Rivera VM. Viruses and multiple sclerosis. JAMA 1977: 238(12): 1247
   PubMed Web of Science ®Google Scholar
• Madigand M, Oger JJ, Fauchet R, et al. HLA profiles in multiple sclerosis suggest two forms of disease and the existence of protective haplotypes. J Neurol Sci 1982: 53(3): 519–29
   PubMed Web of Science ®Google Scholar
• Waksman BH, Reynolds WE. Research on multiple sclerosis. New York: National Multiple Sclerosis Society, 1982
   Google Scholar
• Cohen MM, Lessell S, Wolf PA. A prospective study of the risk of developing multiple sclerosis in uncomplicated optic neuritis. Neurology 1979: 29(2): 208–13
   PubMed Web of Science ®Google Scholar
• Lhermitte J, Bollak, Nicholas M. Les douleurs à type de décharge électrique consécutives à la flexion céphalique dans la sclérose en plaques: un cas de forme sensitive de la sclérose multiple. Rev Neurol (Paris) 1924: 2: 56–62
   Google Scholar
• Kanchandani R, Howe JG. Lhermitte's sign in multiple sclerosis: a clinical survey and review of the literature. J Neurol Neurosurg Psychiatry 1982: 45(4): 308–12
   PubMed Web of Science ®Google Scholar
• Davis FA, Schauf CL, Reed BJ. et al. Experimental studies of the effects of extrinsic factors on conduction In normal and demyelinated nerve. 1. Temperature. J Neurol Neurosurg Psychiatry 1976: 39(5): 442–8
   PubMed Web of Science ®Google Scholar
• Elian M, Bean G. MS and seizures. In: Penry K, ed. Epilepsy. The Eighth International Symposium. New York: Raven Press, 1977: 341
   Google Scholar
• Rivera VM, Breitbach W. Encephalitlc (“cerebral”) forms of multiple sclerosis. Satellite symposium on multiple sclerosis. (Abstr) XIII World Congress of Neurology. Würzburg. West Germany. 1985
   Google Scholar
• Leibowitz U, Antonovsky A, Kats R, et al. Does pregnancy increase the risk of multiple sclerosis? J Neurol Neurosurg Psychiatry 1967: 30(4): 354–7
   PubMed Web of Science ®Google Scholar
• McDonald WI. The role of evoked potentials in the diagnosis of multiple sclerosis. In: Bauer HJ, Poser S. Ritter G. eds. Progress in multiple sclerosis research. New York: Springer-Verlag. 1980
   Google Scholar
• Sears ES, McCammon A, Bigelow R, et al. Maximizing the harvest of contrast-enhancing lesions in multiple sclerosis. Neurology 1982: 32(8): 815–20
   PubMed Web of Science ®Google Scholar
• Rose AS, Ellison GW, Myers LW, et al. Criteria for the clinical diagnosis of multiple sclerosis. Neurology 1976: 26(2): 20–31
   PubMedGoogle Scholar
• Rose AS, Kuzma JW, Kurtzke JF, et al. Cooperative study in the evaluation of therapy in multiple sclerosis: ACTH vs placebo—final report. Neurology 1970: 20(5): 1–59
   PubMed Web of Science ®Google Scholar
• Buckley C, Kennard C, Swash M. Treatment of acute exacerbations of multiple sclerosis with Intravenous methyl-prednisolone. J Neurol Neurosurg Psychiatry 1982: 45(2): 179–80
   PubMed Web of Science ®Google Scholar
• Rivera VM, Huston D, Bressler R, et al. Biological evolution of progressive multiple sclerosis alter treatment with periodic intravenous Cytoxan. Satellite symposium on multiple sclerosis. (Abstr) XIII World Congress of Neurology. Würzburg. West Germany, 1985
   Google Scholar
• Hauser SL, Dawson DM. Lehrich JH, et al. Intensive immunosuppression in progressive multiple sclerosis: a randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. N Engl J Med 1983: 308(4): 173–80
   PubMed Web of Science ®Google Scholar
• Rivera VM, Jerger J, Borday R, et al. Effect of chronic low dose immunosuppression and symptomatic multi-therapy in multiple sclerosis. (Abstr) XII World Congress of Neurology. Kyoto. Japan, 1981
   Google Scholar
• Millar JH, Zilkha KJ, Langman MJ. Double-blind trial of linoleate supplementation of the diet in multiple sclerosis. Br Med J 1973: 1(856): 765–8
   PubMed Web of Science ®Google Scholar
• Neubauer RA. Exposure of multiple sclerosis patients to hyperbaric oxygen at 1.5–2 ATA: a preliminary report. J Fla Med Assoc 1980: 67(5): 498–504
   PubMedGoogle Scholar
• Rivera VM. Intraspinal steroid therapy. (Letter) Neurology 1981: 31(8): 1060–1
   PubMed Web of Science ®Google Scholar